Blog - Page 3648 of 5440

TuesdayMar 23, 2010 12:26 pm

Franklin Wireless (FKWL.OB) Announces Worldwide Launch of U210

Franklin Wireless Corp., a leading developer/marketer of wireless communications devices, today announced the worldwide launch of its U210 USB modem, a single-mode device using EVDO (Evolution Data-Optimized) Rev.A technology, providing the next level of wireless data access for on-the-road notebook and other computers. The U210 was previously launched to a limited number of carriers, but is now available to all of Franklin’s worldwide customers. The U210’s slim design hides its impressive power and flexibility. It supports SMS and operates with Windows, Macintosh, and Linux operating systems. It also contains a built-in GPS receiver. In addition, its microSD memory slot enables…

TuesdayMar 23, 2010 12:23 pm

GeoVax Labs, Inc. (GOVX.OB) Appoints Two Industry Veterans to Board of Directors

GeoVax Labs Inc. is a biotechnology company developing human vaccines for HIV/AIDS and other infectious diseases. The company announced today that it has elected Steven Antebi and David A. Dodd to its board of directors. These appointments bring the number of board members to eight, five of whom are considered independent. Since 1993, Mr. Antebi has been the president and chairman of the board of Maple Capital Management, an equity fund focused on investments in North America. He is also president and CEO of Galileo Partners LLC and president of Blue and Gold Enterprises Inc. These funds invest in registered…

TuesdayMar 23, 2010 12:22 pm

Drinks Americas Holdings Ltd. (DKAM.OB) Announces Improved Fiscal 2010 Third Quarter Operating Results

Drinks Americas Holdings Ltd. develops, owns, markets and nationally distributes alcoholic and non-alcoholic premium beverages associated with renowned icon celebrities. Some of their beverages include Trump Super Premium Vodka and Willie Nelson's Old Whiskey River Bourbon. The company today announced results for the fiscal third quarter ended January 31, 2010. In the third quarter, the company shipped and sold approximately $397,000 in new product. This revenue exceeded Drinks Americas' previous forecast. As reported previously by the company, its second fiscal quarter had only generated $15,000 in shipments and revenues. This low figure was due to severe working capital restraints. The…

TuesdayMar 23, 2010 11:21 am

Consorteum Holdings, Inc. (CSRH.OB) Video Chart for Tuesday, March 23, 2010

The CSRH chart is in a position that is deserving of a closer look. Positive divergence and a solid base are two things that chartists look for in buy points. This video chart takes a look at these and more aspects as to why the Consorteum Holdings, Inc. chart may be poised for a larger move. To view the video, please click the following link: http://www.qualitystocks.net/videocharts.php?chartvid_id=359 Let us hear your thoughts: Consorteum Holdings, Inc. Message Board

TuesdayMar 23, 2010 9:55 am

Rexahn Pharmaceuticals Inc. (RNN) Forms Parkinson’s Disease Scientific Advisory Board for Serdaxin Development

Rexahn Pharmaceuticals Inc., a pharmaceutical company focused on commercializing leading oncology therapeutics, CNS disorders and sexual dysfunction, recently formed a Parkinson’s Disease Scientific Advisory Board (SAB) comprised of leading medical researchers in neurology. The SAB will work with Rexahn for the clinical development strategy for the company’s CNS drug candidate Serdaxin. SAB Chairman Dr. William Weiner is the director of the Maryland Parkinson’s Disease and Movement Disorders Center, and professor and chair of the Department of Neurology at the University of Maryland School of Medicine. With more than 40 years of Parkinson’s disease related research behind him, Dr. Weiner recognizes…

TuesdayMar 23, 2010 7:57 am

Cellceutix Corp. (CTIX.OB) “Low Key” About Product Developments

Yesterday we had a discussion with Mr. Leo Ehrlich, Chief Financial Officer of Cellceutix. Mr. Ehrlich is a very low-key gentleman, but inspired us to want to continue research into CTIX. The first item of discussion in our conversation included the fact that a major cancer hospital (no name was mentioned) will be doing the clinical studies on Kevetrin, their flagship product designed to treat cancer cells that do not respond to typical treatments. Cellceutix hopes that the clinical studies will commence in the third or fourth quarter of this year. Which quarter the studies will begin is dependent on…

TuesdayMar 23, 2010 7:46 am

Consorteum Holdings, Inc. (CSRH.OB) Announces Letter of Intent to Acquire Tenzing Interactive

Today before the opening bell, Consorteum Holdings, Inc. announced that it has entered into a non-binding Letter of Intent to acquire Tenzing Interactive. If finalized, Tenzing Interactive will be a wholly owned subsidiary of Consorteum Inc. According to the terms of the agreement, the purchase price is to be payable over a 2-year period and made up of a combination of cash and shares in Consorteum Holdings Inc. The proposed acquisition is part of Consorteum Holdings’ intent to expand both local and international opportunities. Tenzing Interactive will bring with it new value added partners, allowing Consorteum to achieve its long…

TuesdayMar 23, 2010 7:14 am

Attitude Drinks, Inc. (ATTD.OB) Announces Strong Response from College Testing

Attitude Drinks, Inc., based in Palm Beach Gardens, FL, issued a press release this morning to announce the “overwhelmingly positive response” that they have received from colleges and universities regarding their product, Phase III Recovery. Attitude sent letters to 477 schools covering 14 states along the east coast to introduce their new product and has already received responses from 48 of the schools. Unanimously positive feedback has come from 12 of the 14 states that Attitude has contacted so far. Phase III Recovery was formulated as Grade A milk to enhance physical performance and is the only sports drink recovery…

TuesdayMar 23, 2010 7:12 am

Dr. Maximilien Arella Appointed to Bio-Solutions Corp. (BISU.OB) Advisory Board

Bio-Solutions Corp. issued a press release after the close yesterday to announce the appointment of Dr. Maximilien Arella as the newest member of the Bio-Solutions advisory board. Dr. Arella, a Professor at the Microbiology and Biotechnology Research Centre, INRS - Institut Armand – Frappier (IAF), at the University du Québec in Montreal, is described by Bio-Solutions Ceo and President, Dr. Gilles Chaumillon, as “the brainchild behind the development and implementation of GreenEx”. GreenEx, a malaria combating organic insecticide, is the flagship product of Bio-Solutions. GreenEx has been shown to destroy up to 98% or mosquito larvae within a 24 hour…

TuesdayMar 23, 2010 7:05 am

Emtec, Inc. (ETEC.OB) Welcomes Brian Mandel as Executive Vice President, Public Sector

Yesterday, systems integrator Emtec, Inc. announced that the company has expanded its management team to include Brian Mandel as its new Executive Vice President, Public Sector. The Public Sector division includes Federal, State, Local and Education clients. It specializes in IT transformation and optimization consulting, business service management, enterprise architecture, data management and systems integration services. In his new role, Mr. Mandel will oversee the growth of Emtec’s Public Sector Revenues. Regarding his new appointment, Mr. Mandel commented, “I am truly delighted to join Emtec and be part of such a talented team. I’ve met with the leadership of each…

Site Search

Company Search